Agami R - Search Results

1

MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer.

Bhin J, Yemelyanenko J, Chao X, Klarenbeek S, Opdam M, Malka Y, Hoekman L, Kruger D, Bleijerveld O, Brambillasca CS, Sprengers J, Siteur B, Annunziato S, van Haren MJ, Martin NI, van de Ven M, Peters D, Agami R, Linn SC, Boven E, Altelaar M, Jonkers J, Zingg D, Wessels LFA. Bhin J, et al. Among authors: agami r. J Exp Med. 2023 Nov 6;220(11):e20211743. doi: 10.1084/jem.20211743. Epub 2023 Aug 29. J Exp Med. 2023. PMID: 37642941 Free PMC article.

2

Reducing hypothalamic AGRP by RNA interference increases metabolic rate and decreases body weight without influencing food intake.

Makimura H, Mizuno TM, Mastaitis JW, Agami R, Mobbs CV. Makimura H, et al. Among authors: agami r. BMC Neurosci. 2002 Nov 7;3:18. doi: 10.1186/1471-2202-3-18. BMC Neurosci. 2002. PMID: 12423556 Free PMC article.

3

SCAF4 and SCAF8, mRNA Anti-Terminator Proteins.

Gregersen LH, Mitter R, Ugalde AP, Nojima T, Proudfoot NJ, Agami R, Stewart A, Svejstrup JQ. Gregersen LH, et al. Among authors: agami r. Cell. 2019 Jun 13;177(7):1797-1813.e18. doi: 10.1016/j.cell.2019.04.038. Epub 2019 May 16. Cell. 2019. PMID: 31104839 Free PMC article.

4

AAA ATPase p97/valosin-containing protein interacts with gp78, a ubiquitin ligase for endoplasmic reticulum-associated degradation.

Zhong X, Shen Y, Ballar P, Apostolou A, Agami R, Fang S. Zhong X, et al. Among authors: agami r. J Biol Chem. 2004 Oct 29;279(44):45676-84. doi: 10.1074/jbc.M409034200. Epub 2004 Aug 24. J Biol Chem. 2004. PMID: 15331598 Free article.

5

Genome-Wide Polyadenylation Maps Reveal Dynamic mRNA 3'-End Formation in the Failing Human Heart.

Creemers EE, Bawazeer A, Ugalde AP, van Deutekom HW, van der Made I, de Groot NE, Adriaens ME, Cook SA, Bezzina CR, Hubner N, van der Velden J, Elkon R, Agami R, Pinto YM. Creemers EE, et al. Among authors: agami r. Circ Res. 2016 Feb 5;118(3):433-8. doi: 10.1161/CIRCRESAHA.115.307082. Epub 2015 Dec 15. Circ Res. 2016. PMID: 26671978

6

Functional analysis of cis-acting DNA elements required for expression of the SL RNA gene in the parasitic protozoan Leishmania amazonensis.

Agami R, Aly R, Halman S, Shapira M. Agami R, et al. Nucleic Acids Res. 1994 Jun 11;22(11):1959-65. doi: 10.1093/nar/22.11.1959. Nucleic Acids Res. 1994. PMID: 8029000 Free PMC article.

7

Two-layer design protects genes from mutations in their enhancers.

Elkon R, Agami R. Elkon R, et al. Among authors: agami r. Nature. 2022 Sep;609(7927):477-478. doi: 10.1038/d41586-022-02341-3. Nature. 2022. PMID: 36064783 No abstract available.

8

Enhancer-associated RNAs as therapeutic targets.

Léveillé N, Melo CA, Agami R. Léveillé N, et al. Among authors: agami r. Expert Opin Biol Ther. 2015 May;15(5):723-34. doi: 10.1517/14712598.2015.1029452. Epub 2015 Mar 29. Expert Opin Biol Ther. 2015. PMID: 25819025 Review.

9

Leishmania mexicana amazonensis: effect of heat shock on the spliced leader RNA and its ribonucleoprotein particle SL RNP.

Michaeli S, Agami R, Shapira M. Michaeli S, et al. Among authors: agami r. Exp Parasitol. 1993 Feb;76(1):59-67. doi: 10.1006/expr.1993.1007. Exp Parasitol. 1993. PMID: 8467899

10

The chemokine receptor CXCR4 and the metalloproteinase MT1-MMP are mutually required during melanoma metastasis to lungs.

Bartolomé RA, Ferreiro S, Miquilena-Colina ME, Martínez-Prats L, Soto-Montenegro ML, García-Bernal D, Vaquero JJ, Agami R, Delgado R, Desco M, Sánchez-Mateos P, Teixidó J. Bartolomé RA, et al. Among authors: agami r. Am J Pathol. 2009 Feb;174(2):602-12. doi: 10.2353/ajpath.2009.080636. Epub 2009 Jan 15. Am J Pathol. 2009. PMID: 19147814 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

138 results

Search Page